Stifel sets USD 85.00 target for Establishment Labs stock, 39.07 percent above price

Published on 10/15/2026 at 18:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

On October 15, 2026, the range was USD 44.26 to USD 97.59. Establishment Labs stock costs EUR 54.75 on October 15, 2026, up 5.60 percent on Nasdaq.

Analyst target and valuation

Stifel set an USD 85.00 target on October 14, 2026, 39.07 percent above the Nasdaq quote.
The 52-week range was USD 44.26 to USD 97.59 on October 15, 2026.
Establishment Labs stock cost EUR 54.75 at Lang & Schwarz on October 15, 2026 at 6:30 p.m. CEST, while the Nasdaq quote was up 5.60 percent.
Establishment Labs had a market capitalization of USD 1.8 billion on October 15, 2026.

ESTA, VGG312491084, Illustration mit AI erstellt.

Investing.com reported on October 14, 2026 that Stifel initiated coverage of Establishment Labs Holdings Inc. with a Buy rating and an USD 85.00 price target. Against the USD 61.12 Nasdaq quote at 12:31 p.m. ET on October 15, 2026, that target is 39.07 percent above the price. At Lang & Schwarz, the stock was trading at EUR 54.75 on October 15, 2026 at 6:30 p.m. CEST.

Range spans USD 44.26 to USD 97.59

The stock's 52-week range ran from USD 44.26 to USD 97.59 as of October 15, 2026. The current Nasdaq quote stood 37.44 percent above the yearly low and 37.37 percent below the yearly high, calculated from the same USD range.

Establishment Labs had a market capitalization of USD 1.8 billion on October 15, 2026. The Nasdaq quote was up 5.60 percent on the day, while the available volume was 209,547 shares against an average volume of 431,931 shares.

Valuation carries a negative ratio

The quote carried a negative price-to-earnings ratio of 46.20 and no dividend yield on October 15, 2026. That combination reflects a company still valued primarily on expansion rather than current earnings, while the Stifel target provides a dated external valuation marker.

Comparison with peers

Establishment Labs (Nasdaq, USD): plus 5.60 percent, P/E minus 46.20, market capitalization USD 1.8 billion
Medtronic (NYSE, USD): plus 1.37 percent, P/E 23.53, market capitalization USD 122.2 billion
Intuitive Surgical (Nasdaq, USD): plus 1.18 percent, P/E 48.37, market capitalization USD 150.2 billion

What the target says about valuation

Stifel's USD 85.00 target sits above the latest Nasdaq quote, but the comparison with Medtronic and Intuitive Surgical also shows how different earnings profiles shape medical-device valuations. The price report therefore combines a dated analyst estimate with a wide trading range and a negative earnings ratio rather than a dividend signal.